BAG2 and breast carcinoma: As shown in Figure 7B–E, BAG2 overexpression is associated with poor disease free survival in colorectal cancer patients (HR = 1.40, p = 0.022), poor disease specific survival in lung cancer patients (HR = 2.4, p = 0.00001), poor relapse free survival in breast cancer patients (HR = 1.3, p = 0.00014) and poor distant recurrence free survival in soft tissue cancer patients (HR = 1.67, p = 0.00001).